LifeStance Health Group Inc (LFST) concluded trading on Thursday at a closing price of $7.74, with 4.48 million shares of worth about $34.7 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.81% during that period and on February 27, 2025 the price saw a gain of about 3.06%. Currently the company’s common shares owned by public are about 382.64M shares, out of which, 113.66M shares are available for trading.
Stock saw a price change of -1.90% in past 5 days and over the past one month there was a price change of -5.26%. Year-to-date (YTD), LFST shares are showing a performance of 5.02% which increased to 21.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.64 but also hit the highest price of $9.20 during that period. The average intraday trading volume for LifeStance Health Group Inc shares is 1.17 million. The stock is currently trading -2.01% below its 20-day simple moving average (SMA20), while that difference is down -0.17% for SMA50 and it goes to 15.27% higher than SMA200.
LifeStance Health Group Inc (NASDAQ: LFST) currently have 382.64M outstanding shares and institutions hold larger chunk of about 35.25% of that.
The stock has a current market capitalization of $2.96B and its 3Y-monthly beta is at 1.28. It has posted earnings per share of -$0.25 in the same period. It has Quick Ratio of 1.32 while making debt-to-equity ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LFST, volatility over the week remained 5.39% while standing at 3.30% over the month.
Stock’s fiscal year EPS is expected to rise by 25.98% while it is estimated to increase by 45.22% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on December 16, 2024 offering a Buy rating for the stock and assigned a target price of $10 to it. Coverage by Barclays stated LifeStance Health Group Inc (LFST) stock as an Underweight in their note to investors on January 03, 2024, suggesting a price target of $7 for the stock. On May 15, 2023, TD Cowen Downgrade their recommendations, while on January 06, 2023, Morgan Stanley Upgrade their ratings for the stock with a price target of $8. Stock get a Buy rating from Jefferies on November 07, 2022.
